• OPEN AN ACCOUNT
Indian Indices
Sensex
76,909.68 -325.78
( -0.42%)
Global Indices
Nasdaq
53,360.44 -120.34
(-0.23%)
Dow Jones
7,713.14 -52.92
(-0.68%)
Hang Seng
65,335.94 -2,124.79
(-3.15%)
Nikkei 225
10,735.70 15.40
(0.14%)
Forex
USD-INR
95.60 0.07
(0.07%)
EUR-INR
110.76 0.24
(0.21%)
GBP-INR
129.56 0.29
(0.22%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Gland Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
543245
INE068V01023
655.2871714
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLAND
33.39
47162.32
EPS(TTM)
Face Value()
Div & Yield %
85.62
1
0.7
 

IIFL Finance approves note issuance of $500mn under GMT programme
Jun 04,2026

IIFL Finance approved the pricing, tenure and other terms of the fixed rate, senior, secured notes to be issued by the Company under Regulation S and/or Rule 144A of the U.S. Securities Act 1933 as part of the USD 1,000,000,000 Global Medium Term Note Programme updated by the Company.

  • Type of Instrument - Fixed rate, senior, secured notes (Notes)
  • Size of the Issue -  USD 500,000,000  
  • Tenure - 3.25 years
  • Date of allotment - 10 June 2026
  • Coupon - 7.60% per annum payable semi annually